Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › IBAT inhibitors for the treatment of liver diseases

IBAT inhibitors for the treatment of liver diseases

US Patent 11261212 · Granted Mar 1, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical formulation of odevixibat2025
Treating progressive familial intrahepatic cholestasis (PFIC) with IBAT inhibito2025
Benzothia(di)azepine compounds and their use as bile acid modulators2025
Benzothia(di)azepine compounds and their use as bile acid modulators2025
Benzothia(di)azepine compounds and their use as bile acid modulators2025
Benzothia(di)azepine compounds and their use as bile acid modulators2025
Benzothiadiazepine compounds and their use as bile acid modulators2025
Benzothiadiazepine compounds and their use as bile acid modulators2025
IBAT inhibitors for the treatment of liver diseases2025
IBAT inhibitors for the treatment of liver diseases2025
IBAT inhibitors for the treatment of liver diseases2025
Benzothia(di)azepine compounds and their use as bile acid modulators2024